Towa Pharmaceutical Co., Ltd.
General ticker "TWAPF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $965.0M (TTM average)
Towa Pharmaceutical Co., Ltd. does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 0.0%: low 16.83$, high 16.83$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.27$ (Y1.60%)
Short-term TWAPF quotes
Long-term TWAPF plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥208,859.00MM | ¥227,934.00MM | ¥259,594.00MM |
| Operating Expenses | ¥203,345.00MM | ¥210,287.00MM | ¥236,352.00MM |
| Operating Income | ¥5,514.00MM | ¥17,647.00MM | ¥23,242.00MM |
| Non-Operating Income | ¥-909.00MM | ¥6,812.00MM | ¥3,088.00MM |
| Interest Expense | ¥635.00MM | ¥947.00MM | ¥1,627.00MM |
| R&D Expense | ¥15,265.00MM | ¥13,242.00MM | ¥0.00MM |
| Income(Loss) | ¥4,605.00MM | ¥24,459.00MM | ¥26,330.00MM |
| Taxes | ¥0.00MM | ¥8,286.00MM | ¥7,343.00MM |
| Profit(Loss)* | ¥2,201.00MM | ¥16,173.00MM | ¥18,986.00MM |
| Stockholders Equity | ¥136,893.00MM | ¥155,892.00MM | ¥171,624.00MM |
| Inventory | ¥92,927.00MM | ¥101,072.00MM | ¥108,287.00MM |
| Assets | ¥371,347.00MM | ¥430,653.00MM | ¥470,823.00MM |
| Operating Cash Flow | ¥2,544.00MM | ¥8,212.00MM | ¥23,401.00MM |
| Capital expenditure | ¥30,469.00MM | ¥39,325.00MM | ¥31,223.00MM |
| Investing Cash Flow | ¥-30,284.00MM | ¥-40,394.00MM | ¥-31,287.00MM |
| Financing Cash Flow | ¥17,481.00MM | ¥35,407.00MM | ¥21,567.00MM |
| Earnings Per Share** | ¥44.72 | ¥328.59 | ¥385.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.